학술논문

Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies.
Document Type
Article
Source
ACS Medicinal Chemistry Letters; 7/14/2022, Vol. 13 Issue 7, p1137-1143, 7p
Subject
Language
ISSN
19485875